Table 2 KEGG pathway enrichment analysis
From: Prediction of key genes and pathways involved in trastuzumab-resistant gastric cancer
KEGG pathway | Gene counts | % | p value | FDR | Genes |
|---|---|---|---|---|---|
hsa05200: pathways in cancer | 44 | 5.21 | 5.95E−08 | 7.75E−05 | GNG4,CCND1,STAT1,LAMB3,JUP,SMAD4,ITGA2,RUNX1,WNT5A,KIT,FGFR3,LAMA4,ITGA3,BCL2L1,FZD8,ADCY7,AXIN2,COL4A1,RAC2,COL4A6,LAMC3,SMO,LPAR5,LAMA1,RXRA,PAS1,FGF20,SLC2A1,ERBB2,ITGA6,WNT11,CDH1,TGFA,BMP2,ADCY1,FZD9,BMP4,GNG7,GNB4,KITLG,LAMC2,FGF9,F2R,LAMA5 |
hsa04512: ECM-receptor interaction | 18 | 2.13 | 3.05E−07 | 3.98E−04 | LAMA1,sdc1,LAMB3,ITGA6,ITGA2,ITGB4,ITGA3,LAMA4,THBS1,SV2A,COL4A1,COL6A1,COL4A6,LAMC2,SDC4,CD44,LAMC3,LAMA5 |